Evidence map›Paper›PMID 33987446›Full record

ArticleBioMed research international2021

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints.

Zheng-Yang Zhao, Wen-Zhun Huang, Xin-Ke Zhan, Jie Pan, Yu-An Huang, Shan-Wen Zhang, Chang-Qing Yu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zheng-Yang ZhaoSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0003-2667-1358
Wen-Zhun HuangSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0003-4964-7211
Xin-Ke ZhanSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0002-1235-3220
Jie PanSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0002-4993-298X
Yu-An HuangSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0002-5346-2394
Shan-Wen ZhangSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0002-4534-5358
Chang-Qing YuSchool of Information Engineering, Xijing University, Xi'an 710123, China.ORCID https://orcid.org/0000-0003-4712-8784
Xijing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying the interactions of the drug-target is central to the cognate areas including drug discovery and drug reposition. Although the high-throughput biotechnologies have made tremendous progress, the indispensable clinical trials remain to be expensive, laborious, and intricate. Therefore, a convenient and reliable computer-aided method has become the focus on inferring drug-target interactions (DTIs). In this research, we propose a novel computational model integrating a pyramid histogram of oriented gradients (PHOG), Position-Specific Scoring Matrix (PSSM), and rotation forest (RF) classifier for identifying DTIs. Specifically, protein primary sequences are first converted into PSSMs to describe the potential biological evolution information. After that, PHOG is employed to mine the highly representative features of PSSM from multiple pyramid levels, and the complete describers of drug-target pairs are generated by combining the molecular substructure fingerprints and PHOG features. Finally, we feed the complete describers into the RF classifier for effective prediction. The experiments of 5-fold Cross-Validations (CV) yield mean accuracies of 88.96%, 86.37%, 82.88%, and 76.92% on four golden standard data sets (

Indexed as

Amino Acid SequenceDrug InteractionsMachine LearningComputational BiologyDatabases, ProteinDrug DiscoveryPosition-Specific Scoring MatricesSupport Vector Machine

Identifiers

PMID33987446
PMCPMC8093043
OpenAlexW3158446903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.